Drug firm Ajanta Pharma today said that there is no import alert by the USFDA on the company's manufacturing unit in Aurangabad and it continues to supply to the US market.
"We want to clarify that there is no import alert on us by USFDA and we continue to supply to US market," Ajanta Pharma said in a BSE filing.
There has been media reports saying the company has got import alert from US FDA for its Paithan unit at Aurangabad.
Shares of Ajanta Pharma were trading 4.16 per cent lower at Rs 1,709.50 on BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
